[Skip to Content]
[Skip to Content Landing]
Views 2,624
Citations 0
Health Agencies Update
September 24, 2019

Medicare to Cover CAR T-Cell Therapies

JAMA. 2019;322(12):1133. doi:10.1001/jama.2019.14752

Medicare will now cover chimeric antigen receptor (CAR) T-cell therapies for eligible beneficiaries nationwide, the Centers for Medicare & Medicaid Services (CMS) recently announced.

Over the last 2 years, the US Food and Drug Administration (FDA) approved 2 CAR T-cell therapies to treat some patients with certain types of non-Hodgkin lymphoma and B-cell precursor acute lymphoblastic leukemia.